Fang Li – InmunoES

Peripheral endocrine–nutritional machine learning signature predicts short-term response to neoadjuvant immunochemotherapy in locally advanced gastric cancer

12 de August de 2026 by Fang Li

BackgroundMajor pathological response (MPR) to neoadjuvant PD-1 inhibitor plus chemotherapy in locally advanced gastric cancer (LAGC) varies widely and is incompletely explained by tumor-side biomarkers. Because checkpoint inhibitors act within a host …

An integrated SII-PNI immune-nutritional scoring system predicts efficacy and immune-related adverse events in locally advanced gastric cancer patients undergoing neoadjuvant immunotherapy

30 de April de 2026 by Fang Li

BackgroundImmune checkpoint inhibitors (ICIs) have transformed treatment of locally advanced gastric cancer (LAGC), yet response heterogeneity and immune-related adverse events (irAEs) remain major challenges. Systemic inflammation and nutritional stat…